Standard BioTools Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
171.20 |
169.15 |
189.75 |
206.88 |
229.00 |
| Przychód Δ r/r |
0.00% |
-1.20% |
12.18% |
9.03% |
10.69% |
| Przychód (min) |
168.18 |
167.21 |
186.41 |
205.09 |
224.96 |
| Przychód (max) |
174.24 |
171.09 |
195.01 |
208.67 |
233.07 |
| EBITDA (średnia) |
-95.02 |
-93.88 |
-105.31 |
-114.82 |
-127.10 |
| EBIT (średnia) |
-111.88 |
-110.53 |
-123.99 |
-135.19 |
-149.65 |
| EBIT % |
-65.35% |
-65.35% |
-65.35% |
-65.35% |
-65.35% |
| Zysk netto (średni) |
-126.00 |
-81.80 |
-51.40 |
-6.95 |
-14.13 |
| Zysk netto % |
-73.60% |
-48.36% |
-27.09% |
-3.36% |
-6.17% |
| EPS (średnia) |
-0.36 |
-0.23 |
-0.15 |
-0.02 |
-0.04 |
| Liczba analityków (Przychody) |
2 |
2 |
3 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
2 |
1 |
1 |
| symbol |
LAB |
LAB |
LAB |
LAB |
LAB |